PANATecs

PANATecs is a German biotechnology company specializing in proteomics, peptide synthesis, and immunological services. Founded as a spin-off from the University of Tübingen, the company provides high-end analytical services including mass spectrometry-based protein identification and characterization of biopharmaceuticals. Their service portfolio includes custom peptide synthesis, T-cell assays, and the development of immunological tools for research and clinical applications. In 2014, PANATecs was acquired by the GBA Group, a move that integrated its specialized expertise into GBA's broader pharmaceutical service division. The company's technical capabilities are primarily utilized by pharmaceutical and biotech firms for drug development, quality control, and biomarker discovery. Following the acquisition, the Tübingen site continues to operate as a center of excellence for bioanalytical services within the GBA Group Pharma network.